Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The future of the weight loss market might not revolve around GLP-1 drugs.

If you're searching for more stocks to add to your portfolio this month, here are two quality businesses to consider that ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Novo Nordisk CEO Lars Fruergaard Jorgensen has called attention to the complexities of the U.S. healthcare system while ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight-loss drugs in the UK within weeks, with one leading producer forecasting a “huge price war t ...

The once-weekly injectable joins one-shot haemophilia B gene therapy Beqvez (fidanacogene elaparvovec) in Pfizer’s portfolio, ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Leaders worried the former president could force Ukraine to cede land to Russia in exchange for a ceasefire if he wins the election ...

Elon Musk Unveils the Long-Awaited Robotaxi and Tesla's Autonomous Future ...

Since early September, beachgoers have been reporting sightings of the unusual substance, leaving officials scrambling to determine its origin and composition.